Clinical Trials on 肺癌,非小细胞 in Japan
总计685个结果
-
Kyowa Kirin Co., Ltd.终止
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo未知
-
Tokyo UniversityShionogi; National Cancer Center Hospital East; Hokkaido University; Fukushima Medical University; Kanagawa Cancer Center 和其他合作者未知
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo未知
-
National Hospital Organization Nagoya Medical CenterMerck Sharp & Dohme LLC; Central Japan Lung Study Group主动,不招人
-
Masahiro TsuboiEli Lilly and Company; Merck Sharp & Dohme LLC招聘中非小细胞肺癌 II 期 | 非小细胞肺癌 IB 期 | 非小细胞肺癌ⅢA期日本
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Kyowa Kirin Co., Ltd.完全的
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Kobe City General Hospital终止
-
Kyowa Kirin Co., Ltd.完全的
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Eisai Co., Ltd.完全的
-
Kyoto UniversityTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan未知
-
Astellas Pharma Global Development, Inc.终止
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Bristol-Myers Squibb完全的
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd完全的
-
Eli Lilly and Company完全的
-
Merck Sharp & Dohme LLC完全的
-
Eli Lilly and Company完全的
-
Juntendo UniversityMerck Sharp & Dohme LLC主动,不招人
-
Bristol-Myers SquibbOno Pharma USA Inc完全的
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, Japan完全的
-
AstraZeneca主动,不招人非小细胞肺癌法国, 西班牙, 泰国, 比利时, 大韩民国, 荷兰, 美国, 巴西, 日本, 中国, 马来西亚, 台湾, 澳大利亚, 丹麦
-
Merck Sharp & Dohme LLC主动,不招人
-
Eli Lilly and CompanyMerck Sharp & Dohme LLC完全的